(firstQuint)A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-981 in Patients With Osteoarthritis of the Knee.

 This is a phase 1, randomized, double-blind, placebo-controlled, multiple ascending dose study.

 Thirty-six patients with osteoarthritis of the knee will be selected to participate.

 Patients will be randomized to receive either ABT-981 or placebo.

 ABT-981 or placebo will be administered as subcutaneous (under the skin) injections in four dosing groups.

 Subjects will be administered subcutaneous injections of ABT-981 for up to 8 weeks.

.

 A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-981 in Patients With Osteoarthritis of the Knee@highlight

To assess the safety, tolerability and pharmacokinetics of ABT-981 in patients with osteoarthritis of the knee.

